AI-Based Grading of Facial Aging Signs and Prediction of Visible Age From Standardized Facial Images: Algorithm Development and Internal Evaluation Study.
4 affiliations
- 1L'Oréal Research and Innovation, 9 rue Pierre Dreyfus, Clichy, 92110, France, 33 149795334, 33 149795142.
- 2Eurosyn, Villebon-sur-Yvette, France.
- 3Centre Médical Laser Palaiseau, private practice, Palaiseau, France.
- 4Centre Médical Saint Jean, Arras, France.
Abstract
Background
Facial appearance influences visible age (VA), defined here as the age perceived by others; this perception-based outcome differs from chronological age and biological age. Human evaluation of facial aging signs can be time-consuming and subject to interobserver variability. A standardized AI-based approach might offer a more reproducible assessment of visible facial aging in digital dermatology research.Objective
This study aimed to develop and evaluate an AI-based process for automatically grading facial aging signs and predicting the VA of participants from standardized full-face images.Methods
Evaluation of full-face photographs of 468 North American women aged 18 to 80 years recruited in Dallas and Phoenix, Texas. Fifteen trained experts, including dermatologists, graded 13 aging signs using Skin Aging Atlas scales. A separate, naïve group of 253 North Americans aged 20 to 60 years, recruited in New York City, estimated the VA of each participant. For each sign, facial areas were pulled out using facial landmarks and fed into ResNet-based regression models, which were trained to match the averaged expert scores. The automated facial sign grading models were tested on 90% of the image set, and the remaining 10% was used for evaluation. Results were assessed using the mean absolute error, the proportions of estimates within 0.5, 1.0, and 1.5 grading units of the expert reference, and Spearman correlations between chronological age, human-assessed VA, and predicted visible age (PVA).Results
The mean absolute error was below 0.3 grading units for 11 of the 13 facial aging signs. The average proportion of automatic gradings within 1 grading unit of the expert reference was about 98% for participants of East Asian ancestry group, 96% for participants of African ancestry group, and 97% for participants of European ancestry group. Human-assessed VA correlated strongly with real age (r=0.94, 95% CI 0.928-0.950; P<.001), although participants were perceived as around 10 years older than their real age, on average. The AI-PVA also correlated strongly with the human-assessed VA (r=0.93, 95% CI 0.917-0.941; P<.001), with approximately 70% of estimates within 5 years.Conclusions
The AI-based system showed low grading errors across most facial aging signs and also a fairly strong relationship between the PVA and human-assessed VA under standardized image acquisition conditions. Consequently, the system could provide a reproducible digital outcome for facial aging research and future longitudinal monitoring. However, external validation across separate populations, in men, and across image acquisition devices is required before clinical and consumer-facing implementation. As the predicted visible age is derived from quantified clinical facial signs, it reflects measurable features of visible facial aging, while its relationship with biological age and overall health remains to be established through future studies integrating biological biomarkers.
Related
- Development and internal validation of an exploratory clinical prediction model for MRI-defined white matter injury in moderate-to-late preterm infants: a single-center retrospective study
- Development and internal validation of a machine learning prediction model for postoperative hemorrhage following modified radical mastectomy for breast cancer
- Development and Internal Validation of a Prediction Model Incorporating Respiratory Muscle Function for CAT Score Deterioration in Stable COPD
- Development and internal validation of a prediction model for postpartum haemorrhage following caesarean delivery in a resource-limited setting in Ethiopia
- Prediction of Six-Month Glycemic Status in Type 2 Diabetes: Development and Internal Validation of a Multivariable Model
BibTeX
@article{flament2026aibased,
title = {{AI-Based Grading of Facial Aging Signs and Prediction of Visible Age From Standardized Facial Images: Algorithm Development and Internal Evaluation Study.}},
author = {Frederic Flament and Panagiotis-Alexandros Bokaris and Tao Li and Aurelie Abric and Sileye Ba and Julien Despois and Hussein Jouni and Laudine Bertrand and Paul Michel and Thomas Dauxerre and Diala Haykal and Hughes Cartier},
journal = {JMIR dermatology},
year = {2026},
month = oct,
doi = {10.2196/93236},
url = {https://europepmc.org/article/MED/42950221},
note = {CC BY},
}
RIS
TY - JOUR
TI - AI-Based Grading of Facial Aging Signs and Prediction of Visible Age From Standardized Facial Images: Algorithm Development and Internal Evaluation Study.
AU - Frederic Flament
AU - Panagiotis-Alexandros Bokaris
AU - Tao Li
AU - Aurelie Abric
AU - Sileye Ba
AU - Julien Despois
AU - Hussein Jouni
AU - Laudine Bertrand
AU - Paul Michel
AU - Thomas Dauxerre
AU - Diala Haykal
AU - Hughes Cartier
PY - 2026
DA - 2026/10/01
JO - JMIR dermatology
DO - 10.2196/93236
UR - https://europepmc.org/article/MED/42950221
AB - Background Facial appearance influences visible age (VA), defined here as the age perceived by others; this perception-based outcome differs from chronological age and biological age. Human evaluation of facial aging signs can be time-consuming and subject to interobserver variability. A standardized AI-based approach might offer a more reproducible assessment of visible facial aging in digital dermatology research.Objective This study aimed to develop and evaluate an AI-based process for automatically grading facial aging signs and predicting the VA of participants from standardized full-face images.Methods Evaluation of full-face photographs of 468 North American women aged 18 to 80 years recruited in Dallas and Phoenix, Texas. Fifteen trained experts, including dermatologists, graded 13 aging signs using Skin Aging Atlas scales. A separate, naïve group of 253 North Americans aged 20 to 60 years, recruited in New York City, estimated the VA of each participant. For each sign, facial areas were pulled out using facial landmarks and fed into ResNet-based regression models, which were trained to match the averaged expert scores. The automated facial sign grading models were tested on 90% of the image set, and the remaining 10% was used for evaluation. Results were assessed using the mean absolute error, the proportions of estimates within 0.5, 1.0, and 1.5 grading units of the expert reference, and Spearman correlations between chronological age, human-assessed VA, and predicted visible age (PVA).Results The mean absolute error was below 0.3 grading units for 11 of the 13 facial aging signs. The average proportion of automatic gradings within 1 grading unit of the expert reference was about 98% for participants of East Asian ancestry group, 96% for participants of African ancestry group, and 97% for participants of European ancestry group. Human-assessed VA correlated strongly with real age (r=0.94, 95% CI 0.928-0.950; P<.001), although participants were perceived as around 10 years older than their real age, on average. The AI-PVA also correlated strongly with the human-assessed VA (r=0.93, 95% CI 0.917-0.941; P<.001), with approximately 70% of estimates within 5 years.Conclusions The AI-based system showed low grading errors across most facial aging signs and also a fairly strong relationship between the PVA and human-assessed VA under standardized image acquisition conditions. Consequently, the system could provide a reproducible digital outcome for facial aging research and future longitudinal monitoring. However, external validation across separate populations, in men, and across image acquisition devices is required before clinical and consumer-facing implementation. As the predicted visible age is derived from quantified clinical facial signs, it reflects measurable features of visible facial aging, while its relationship with biological age and overall health remains to be established through future studies integrating biological biomarkers.
SN - 2562-0959
ER -